News

Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment, today announced the launch of the VARIPULSEâ„¢ Platform in Asia-Pacific. The platform is used to perform catheter ablation ...
A new preclinical study from Monash University has uncovered the role of the female sex hormone estrogen in protecting the ...
Atrial fibrillation (Afib) is one of the most common heart rhythm disorders, affecting millions worldwide. It occurs when the ...